SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCHINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.011
AS - Asia 3.773
EU - Europa 3.060
SA - Sud America 524
Continente sconosciuto - Info sul continente non disponibili 131
AF - Africa 91
OC - Oceania 8
Totale 15.598
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.788
SG - Singapore 1.364
CN - Cina 999
PL - Polonia 682
VN - Vietnam 431
DE - Germania 421
RU - Federazione Russa 412
IT - Italia 411
BR - Brasile 390
UA - Ucraina 293
GB - Regno Unito 252
HK - Hong Kong 244
TR - Turchia 204
FI - Finlandia 196
BD - Bangladesh 162
CA - Canada 131
FR - Francia 128
JP - Giappone 90
IN - India 84
SE - Svezia 59
AR - Argentina 51
MX - Messico 50
ID - Indonesia 40
ES - Italia 39
ZA - Sudafrica 35
IQ - Iraq 33
NL - Olanda 30
CZ - Repubblica Ceca 28
AT - Austria 27
EC - Ecuador 25
PK - Pakistan 24
LT - Lituania 19
CO - Colombia 18
VE - Venezuela 17
MA - Marocco 16
BE - Belgio 14
SA - Arabia Saudita 13
CL - Cile 12
JM - Giamaica 11
AE - Emirati Arabi Uniti 10
MY - Malesia 9
PH - Filippine 8
AU - Australia 7
EG - Egitto 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
PT - Portogallo 7
UZ - Uzbekistan 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
HN - Honduras 6
CH - Svizzera 5
DZ - Algeria 5
PA - Panama 5
RS - Serbia 5
BY - Bielorussia 4
CR - Costa Rica 4
GT - Guatemala 4
IL - Israele 4
KR - Corea 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
GE - Georgia 3
GR - Grecia 3
IE - Irlanda 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
PY - Paraguay 3
SI - Slovenia 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
SN - Senegal 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
DM - Dominica 1
EE - Estonia 1
GN - Guinea 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
Totale 15.459
Salva come PNG Salva come JPEG
Città #
Ashburn 1.027
Singapore 869
Fairfield 683
Warsaw 670
Woodbridge 645
San Jose 606
Houston 395
Beijing 376
Chandler 343
Jacksonville 315
Santa Clara 307
Seattle 265
Ann Arbor 256
Wilmington 243
Hong Kong 242
Munich 204
Cambridge 198
Council Bluffs 191
New York 156
Los Angeles 153
Ho Chi Minh City 135
Ferrara 118
Hanoi 108
Nanjing 106
Izmir 104
Helsinki 100
Dallas 94
Tokyo 89
Milan 71
Princeton 71
San Diego 61
Shanghai 56
Lauterbourg 55
Orem 54
São Paulo 43
Boardman 41
Buffalo 40
Washington 40
Brooklyn 35
Montreal 35
London 34
Toronto 34
Phoenix 33
Turku 31
Chicago 30
Chennai 29
Frankfurt am Main 29
Jakarta 29
Denver 28
Boston 26
Mexico City 25
Nanchang 25
Atlanta 24
Bologna 23
Da Nang 22
Stockholm 22
Hebei 21
Johannesburg 21
Poplar 21
San Francisco 20
Moscow 19
Vienna 19
Amsterdam 18
Falkenstein 18
Vancouver 18
Brno 17
Jiaxing 17
Manchester 17
Rome 17
Norwalk 16
Shenyang 16
The Dalles 16
Auburn Hills 14
Dearborn 14
Haiphong 14
Hefei 14
Falls Church 13
Mcallen 13
Rio de Janeiro 13
Tianjin 13
Ankara 12
Baghdad 12
Montréal 12
Quito 12
Brussels 11
Mountain View 11
Nuremberg 11
Brasília 10
Bremen 10
Changsha 10
Columbus 10
Guangzhou 10
Mumbai 10
Turin 10
Guayaquil 9
Hải Dương 9
Ningbo 9
San Mateo 9
Dong Ket 8
Guarulhos 8
Totale 10.646
Salva come PNG Salva come JPEG
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 644
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 414
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 407
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 389
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 380
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 326
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 277
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 276
Personalized needles for microinjections in the rodent brain 257
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 253
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 252
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 250
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 249
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 249
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 237
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 234
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 228
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 226
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 223
Gene Therapy Tools for Brain Diseases 220
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb 216
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 216
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 215
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 214
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 213
Fibroblast Growth Factor-2 (FGF-2). 212
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 211
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 209
Involvement of the neuropeptide orphanin FQ/nociceptin in kainate and kindling seizures and epileptogenesis 209
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 209
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 208
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 204
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 202
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 200
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 197
Properties and maturation of adult-generated dopaminergic neurons in the mammalian olfactory bulb 196
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 193
Temporal lobe epilepsy model, neural stem cells and gene therapy 191
Implication of sestrin3 in epilepsy and its comorbidities 191
Mechanisms of action of CHF3381 in the forebrain 189
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 189
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 183
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 182
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 182
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development 174
Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). 174
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 172
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 172
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 171
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 164
Different patterns of induction of fibroblast growth factor-2 and brain-derived neurotrophic factor messenger RNAs during kindling epileptogenesis, and development of a herpes simplex vector for fibroblast growth factor-2 gene transfer in vivo 163
Increased susceptibility to kainate seizures and decreased seizure-induced cell loss in transgenic mice overexpressing fibroblast growth factor-2 163
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings 162
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 159
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 157
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells 156
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 153
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease 151
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models 149
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 137
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy 135
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 133
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 131
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats 130
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? 128
Gene therapy of the nervous system by herpes virus vectors 125
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 121
Molecular approaches to inhibit HIV-1 tat expression and functions 112
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 103
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist 103
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. 101
null 97
Possible Approaches of Gene Therapy of AIDS. 97
null 94
null 94
null 93
null 92
null 89
null 89
null 89
null 43
Totale 15.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.007
Totale 66.787
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022617 0 0 61 24 27 28 47 42 20 48 69 251
2022/2023734 74 44 48 75 119 101 38 77 100 4 40 14
2023/2024881 41 46 41 12 48 222 89 97 66 62 50 107
2024/20252.055 55 47 152 114 215 264 86 109 324 157 253 279
2025/20265.692 654 194 397 756 830 416 699 274 498 522 301 151
2026/2027531 130 284 117 0 0 0 0 0 0 0 0 0
Totale 15.598